HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
RecruitingNCT05748808

Use of Biofeedback and Virtual Reality as Facilitators of Emotional Recognition in the Treatment of Aggressive Outbursts

This study is recruiting. It focuses on personality disorders and currently lists participation information in Spain.

Personality disorders, Passive-Aggressive Personality DisorderBehavioralFrom 10 Years to 16 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 10 years to 16 years.

Listed locations
Seville, SpainSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: September 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
University of Seville
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Spain
Age range
From 10 Years to 16 Years
Official registry ID
NCT05748808
Official title
Use of Biofeedback and Virtual Reality as Facilitators of Emotional Recognition in the Treatment of Aggressive Outbursts

Want help reviewing this study?

Loading the security check...
Study ID: NCT05748808. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Recruiting

Seville

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Passive-Aggressive Personality Disorder

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Seville, a university.

Who can participate?

Listed age limits: 10 years to 16 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
RecruitingEUCTR 2022-003670-22

Controlled and randomized clinical trial to evaluate the efficacy of the combination of oxytocin plus self-compassion training in patients with Borderline Personality Disorder Ensayo clínico controlado y aleatorizado para evaluar la eficacia de la combinación de oxitocina más entrenamiento en autocompasión en pacientes con Trastorno Límite de Personalidad

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.